Company Overview and News
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
The equity market continued to trade on a positive note on Friday afternoon, with the Nifty trading 70 points up at 10,787 and the Sensex trading 215 points higher at 35,461.
The equity market was trading on a positive note on Friday afternoon. The Nifty is up 33 points at 10,750 levels and the Sensex is trading 79 points higher, or up 0.23 percent.
The Indian equity market was trading on flat note and shed the morning gains with the Nifty shedding 4 points and was trading at 10,737 while the Sensex was up 13 points or 0.04 percent.
The Indian equity market extended loses was trading on a negative note on Friday afternoon with the Nifty falling 54 points was trading at 10,624 while the Sensex was down 179 points or 0.51 percent.
The Indian equity market extended loses was trading on a negative note on Thursday afternoon with the Nifty falling 58 points was trading at 10,659 while the Sensex was down 125 points or 0.26 percent.
Mumbai: Penna Cement Industries Ltd is planning to raise Rs1,300 crore through an initial public offering (IPO) and will file its draft offer documents with the markets regulator in the next two months, two people close to the development said.
3:30 pm Market Closing: Benchmark indices closed lower ahead of expiry of April derivative contracts due tomorrow.
The number of billionaires in India has increased by 19 to 121 according to the latest annual Forbes’ Billionaires List. Indians now account for the third largest pool of billionaires in the world after the Americans and the Chinese.
The Indian equity market continued trading on a positive note on Friday afternoon with the Nifty adding 33 points and was trading just below the 10,500 mark at 10,491 while the Sensex was up 126 points or 0.37 percent.
The Indian equity market was trading on a positive note on Friday morning with the Nifty adding 38 points and was trading just below the 10,500 mark at 10,497 while the Sensex was up 145 points or 0.43 percent.
Serious Fraud Investigation Office (SFIO) summons ICICI Bank Managing Director and CEO Chanda Kochhar and Axis Bank MD Shikha Sharma in the Rs 12,700 crore Punjab National Bank fraud case, reports CNN-News18.
The Central Bureau of Investigation has detained Vipul Chitalia, Vice President (Banking Operations) of Gitanjali Group, in Mumbai in the Rs 12,700 crore Punjab National Bank fraud case, reports PTI.
Mutual funds have raised their stakes in at least 10 small and midcap stocks for eight consecutive quarters on the trot, data compiled from database Capitaline showed. The stocks have risen up to 200% during the said period. These include Tata Chemicals, India Cements, Carborundum Universal, Oriental Carbon Chemicals, JK Cements, Deccan Cements, VST Industries, GHCL, Symphony and Entertainment Network.
2018-05-19 - Asif
OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...
2018-05-19 - Asif
Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...
2018-05-17 - Asif
Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...